Skip to main content
GutCited
Figure 4

Description

Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.

More Figures from This Paper

Illustration of Saccharomyces boulardii CNCM I-745 mechanisms of action in the intestinal lumen, showing direct antimicrobial effects and pathogen binding at the gut epithelial surface.

Figure 2

Illustration of Saccharomyces boulardii CNCM I-745 mechanisms of action in the intestinal lumen, showing direct antimicrobial effects and pathogen binding at the gut epithelial surface.

diagram
Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.

Figure 3

Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.

diagram
Diagram of S. boulardii's immunomodulatory actions in the gut, illustrating effects on secretory IgA production, anti-inflammatory cytokine release, and immune cell regulation.

Figure 5

Diagram of S. boulardii's immunomodulatory actions in the gut, illustrating effects on secretory IgA production, anti-inflammatory cytokine release, and immune cell regulation.

diagram
Diagram of S. boulardii's immunomodulatory actions in the gut, illustrating effects on secretory IgA production, anti-inflammatory cytokine release, and immune cell regulation.

Figure 6

Diagram of S. boulardii's immunomodulatory actions in the gut, illustrating effects on secretory IgA production, anti-inflammatory cytokine release, and immune cell regulation.

diagram
Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.

Figure 7

Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.

diagram
Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.

Figure 8

Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.

diagram

Figure 4

Diagram
850 × 403px · 213,6 Kio

Source Paper

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.

World journal of gastroenterology (2019)

PMID: 31143070

DOI: 10.3748/wjg.v25.i18.2188

Cite This Figure

![Figure 4: Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.](https://pdfs.citedhealth.com/figures/31143070/163.png)

> Source: Dorota Czerucka et al. "Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against int." *World journal of gastroenterology*, 2019. PMID: [31143070](https://pubmed.ncbi.nlm.nih.gov/31143070/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/31143070/163.png" alt="Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement." />
  <figcaption>Figure 4. Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.<br>  Source: Dorota Czerucka et al. "Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against int." <em>World journal of gastroenterology</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31143070/">31143070</a></figcaption>
</figure>

Preuves associées

A
Saccharomyces boulardii pour Antibiotic-Associated Diarrhea (AAD)

Note A · 25 études

 B
Saccharomyces boulardii pour Traveler's Diarrhea

Note B · 4 études